Clinica Chimica Acta

杂志介绍

Clinica Chimica Acta杂志介绍

《Clinica Chimica Acta》是一本以English为主的未开放获取国际优秀期刊，中文名称Acta 化学诊所，本刊主要出版、报道医学-MEDICAL LABORATORY TECHNOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为3.2，最新CiteScore 指数为10.1。

本刊近期中国学者发表的论文主要有：

• A rapid multiplex assay of human malaria parasites by digital PCR

  Author: Dong, Liu; Li, Weijia; Xu, Qianqian; Gu, Jianfei; Kang, Zhihua; Chen, Jian; Xu, Xiao; Zhang, Xinju; Zhang, Xiuming; Jiang, Haoqin; Guan, Ming

• The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects

  Author: Fang, Yiwei; Zhang, Zheng; Zhao, Yun; Sun, Guoqiang; Peng, Meilin; Liu, Chunyan; Yi, Guilin; Zhao, Kai; Yang, Hui

• Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway

  Author: Dong, Liu; Jiang, Haoqin; Kang, Zhihua; Guan, Ming

• Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy

  Author: Huang, Ziyue; Wang, Zhensheng; Xia, Haoming; Ge, Ziqiang; Yu, Liang; Li, Jiehan; Bao, Haolin; Liang, Zixin; Cui, Yunfu; Xu, Yi

英文介绍

Clinica Chimica Acta杂志英文介绍

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.